Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 783 M867 M863 M836 M867 M 3.43 B Research & development ————— — Operating income 687 M2.2 B2.71 B2.69 B1.4 B 9.01 B Non-Operating Income, Total 41 M25 M35 M35 M28 M 123 M Interest expense, net of interest capitalized 334 M337 M341 M377 M386 M 1.44 B Non-Operating Income, excl. Interest Expenses -293 M-312 M-306 M-342 M-358 M -1.32 B Unusual income/expense ————— — Pretax income 383 M1.88 B2.4 B2.35 B1.03 B 7.67 B Equity in earnings 230 M212 M976 M204 M176 M 1.57 B Taxes 37 M268 M460 M372 M183 M 1.28 B Non-controlling/minority interest 420 M394 M573 M444 M340 M 1.75 B After tax other income/expense ————— — Net income before discontinued operations -74 M1.22 B1.37 B1.53 B511 M 4.63 B Discontinued operations ————— — Net income -74 M1.22 B1.37 B1.53 B511 M 4.63 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -74 M1.22 B1.37 B1.53 B511 M 4.63 B Basic earnings per share (Basic EPS) -0.243.964.515.011.73 15.21 Diluted earnings per share (Diluted EPS) -0.243.964.514.991.73 15.19 Average basic shares outstanding 313 M307 M303 M305 M295 M — Diluted shares outstanding 313 M307 M304 M306 M295 M — EBITDA 1.15 B2.68 B2.51 B2.67 B1.84 B 9.72 B EBIT 354 M1.9 B1.67 B1.85 B1.04 B 6.45 B Cost of revenue 29.36 B30.02 B31.2 B28.86 B31.26 B 121.35 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 793 M789 M841 M828 M809 M 3.27 B